Related Experiment Video
Updated: Jun 15, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Kytococcus schroeteri pneumonia in two patients with a hematological malignancy
C J Hodiamont1, C Huisman, L Spanjaard
1Dept. of Medical Microbiology, Room L1-245, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. c.j.hodiamont@amc.uva.nl
Neutropenic patients can develop severe infections from common skin bacteria. Kytococcus schroeteri, a skin saprophyte, caused severe pneumonia in two hematological patients, highlighting the need for specific antimicrobial therapy.
Area of Science:
- Microbiology
- Infectious Diseases
- Hematology
Background:
- Neutropenic patients exhibit increased susceptibility to opportunistic infections.
- Infections caused by commensal microorganisms pose a significant risk in immunocompromised individuals.
Observation:
- Two cases of severe pneumonia occurred in hematological patients.
- The causative agent identified was Kytococcus schroeteri, a skin saprophyte.
Findings:
- Kytococcus species can cause severe pneumonia in neutropenic patients.
- Kytococcus species often display resistance to penicillin.
- Micrococcus-like colonies in cultures may indicate Kytococcus species.
Implications:
- Diagnostic consideration of Kytococcus species is crucial when encountering micrococcus-like colonies in clinical specimens.
- Antimicrobial therapy must be adjusted to account for potential penicillin resistance in Kytococcus infections.
- This highlights the importance of identifying specific pathogens in neutropenic patients to guide effective treatment.
Related Concept Videos
Cryptococcal Meningitis
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

